Maelstrom Research Staging | SIC_Underlying_medical_conditions_Clinical

SIC_Underlying_medical_conditions_Clinical_assessment

Networks -

Variables -

Population

SIC – Underlying medical conditions

The population is composed of patients with underlying medical conditions who are hypersensitive to a component of a COVID-19 vaccine and require a pre-vaccination assessment.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Halifax, Quebec City, Montreal, Sherbrooke, Ottawa, Toronto, Hamilton, Saskatoon, Edmonton, Calgary, Vancouver

Ethnic Origin

Health Status

Patients with underlying medical conditions who are hypersensitive to a component of a COVID-19 vaccine and require a pre-vaccination assessment

Other Criteria

Patients with vaccine hesitancy or concerns will be excluded from the study.

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Participants are referred to the study by a healthcare provider (physician, nurse practitioner, public health physician).

Number of Participants

Number of Participants
Number of Participants with Biological Samples

More info

Data Collection Event

SIC - Underlying medical conditions - Clinical assessment

Information was or will be collected on age, gender, past medical history, comorbidities, known allergies and medication history, history of symptomatic or asymptomatic SARS-CoV-2 infection or contact with COVID-19, and the risk-benefit ratio of vaccination. Physical measures included or will include but are not limited to allergy skin testing and diagnostic imaging for a subset of the population. Blood samples were or will be collected for a subset of the population.

More info

Collected Dataset / SIC_Underlying_medical_conditions_Clinical_assessment

SIC_Underlying_medical_conditions_Clinical_assessment

Population

SIC – Underlying medical conditions

Data Collection Event

SIC - Underlying medical conditions - Clinical assessment

Files

Variables Classifications